» Articles » PMID: 11190032

Acquired Color Vision Loss and a Possible Mechanism of Ganglion Cell Death in Glaucoma

Overview
Specialty Ophthalmology
Date 2001 Feb 24
PMID 11190032
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: First, to study the cellular mechanisms of acquired color vision loss in retinal detachment and diabetic retinopathy. Second, to learn why, in glaucoma, the type of color vision deficit that is observed is more characteristic of a retinal injury than it is of an optic neuropathy. Third, to test a hypothesis of photoreceptor-induced, ganglion cell death in glaucoma.

Methods: Various histologic techniques were employed to distinguish the L/M-cones (long/medium wavelength-sensitive cones, or red/green sensitive cones) from the S-cones (short wavelength-sensitive cones, or blue sensitive cones) in humans and monkeys with retinal detachment, humans with diabetic retinopathy, and both humans and monkeys with glaucoma. To test if the photoreceptors were contributing to ganglion cell death, laser photocoagulation was used in a experimental model of glaucoma to focally eliminate the photoreceptors. As a control, optic nerve transection was done following retinal laser photocoagulation in one animal.

Results: Selective and widespread loss of the S-cones was found in retinal detachment as well as diabetic retinopathy. By contrast, in human as well as experimental glaucoma, marked swelling of the L/M-cones was the predominant histopathologic feature. Retinal laser photocoagulation followed by experimental glaucoma resulted in selective protection of ganglion cells overlying the laser spots. This was not seen with retinal laser photocoagulation by optic nerve transection.

Conclusions: In retinal detachment and diabetic retinopathy, acquired tritan-like color vision loss could be caused, or contributed to, by selective loss of the S-cones. Both L- and M-cones are affected in glaucoma, which is also consistent with a tritan-like deficit. Although not a therapeutic option, protection of ganglion cells by retinal laser in experimental glaucoma is consistent with an hypothesis of anterograde, photoreceptor-induced, ganglion cell death.

Citing Articles

Injury to Cone Synapses by Retinal Detachment: Differences from Rod Synapses and Protection by ROCK Inhibition.

Townes-Anderson E, Halasz E, Sugino I, Davidow A, Frishman L, Fritzky L Cells. 2023; 12(11).

PMID: 37296606 PMC: 10253016. DOI: 10.3390/cells12111485.


Multifocal electroretinography increases following experimental glaucoma in nonhuman primates with retinal ganglion cell axotomy.

Nork T, Kim C, Katz A, Rasmussen C, Banghart M, Ver Hoeve J Doc Ophthalmol. 2023; 146(2):97-112.

PMID: 36763214 PMC: 10284020. DOI: 10.1007/s10633-023-09922-1.


Visual function tests for glaucoma practice - What is relevant?.

Rao A, Padhy D, Pal A, Roy A Indian J Ophthalmol. 2022; 70(3):749-758.

PMID: 35225508 PMC: 9114550. DOI: 10.4103/ijo.IJO_1390_21.


Differential Effects of Experimental Retinal Detachment on S- and M/L-Cones in Rats.

Chidlow G, Chan W, Wood J, Casson R Mol Neurobiol. 2021; 59(1):117-136.

PMID: 34633652 DOI: 10.1007/s12035-021-02582-9.


Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Retinal Degenerative Diseases.

Rajala R J Mol Biol Ther. 2021; 1:44-55.

PMID: 34528026 PMC: 8439377.


References
1.
Wygnanski T, Desatnik H, Quigley H, Glovinsky Y . Comparison of ganglion cell loss and cone loss in experimental glaucoma. Am J Ophthalmol. 1995; 120(2):184-9. DOI: 10.1016/s0002-9394(14)72606-6. View

2.
Kaiser H, Schoetzau A, Stumpfig D, Flammer J . Blood-flow velocities of the extraocular vessels in patients with high-tension and normal-tension primary open-angle glaucoma. Am J Ophthalmol. 1997; 123(3):320-7. DOI: 10.1016/s0002-9394(14)70127-8. View

3.
Quigley H, Addicks E, Green W, MAUMENEE A . Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981; 99(4):635-49. DOI: 10.1001/archopht.1981.03930010635009. View

4.
Adams A . Chromatic and luminosity processing in retinal disease. Am J Optom Physiol Opt. 1982; 59(12):954-60. DOI: 10.1097/00006324-198212000-00004. View

5.
Kaiser H, Flammer J, Stumpfig D, Hendrickson P . Longterm visual field follow-up of glaucoma patients treated with beta-blockers. Surv Ophthalmol. 1994; 38 Suppl:S156-9; discussion S160. DOI: 10.1016/0039-6257(94)90060-4. View